ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Nephrology

Top Nephrology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KANCHAN ANAND MD

Nephrology

1,051

$87K

85
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $114

NAMRITA BAVEJA M.D.

Nephrology

1,042

$110K

175
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $114

RUSSELL ELLENBERG MD

Nephrology

1,008

$229K

67
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$227
Average prescription price

Avg: $114

SAJID GEORGE M.D

Nephrology

998

$55.7K

228
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $114

THOMAS RAKOWSKI M.D.

Nephrology

998

$198K

99
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 28%

$199
Average prescription price

Avg: $114

ALI CHOUDHURY MD

Nephrology

982

$258K

123
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 28%

$262
Average prescription price

Avg: $114

UTA ERDBRUEGGER MD

Nephrology

975

$71.1K

129
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $114

MADHU KOLLI MD

Nephrology

953

$128K

154
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$134
Average prescription price

Avg: $114

EUGENE KIM M.D.

Nephrology

952

$81.1K

115
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $114

KHALIL DAHDAH MD

Nephrology

940

$213K

147
42 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

39%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 28%

$226
Average prescription price

Avg: $114

OSCAR ADLER M.D., PHD

Nephrology

918

$89.9K

123
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$98
Average prescription price

Avg: $114

YAO-FOLI SEKYEMA M.D.

Nephrology

904

$179K

123
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$198
Average prescription price

Avg: $114

PATRICIA KAO M.D.

Nephrology

872

$89.9K

114
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$103
Average prescription price

Avg: $114

SUDHAKAR RELTON MD

Nephrology

854

$116K

127
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$136
Average prescription price

Avg: $114

MITCHELL ROSNER

Nephrology

836

$105K

60
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$126
Average prescription price

Avg: $114

CAROL CHANG M.D.

Nephrology

836

$102K

118
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$122
Average prescription price

Avg: $114

MOHAMMAD SANAEI ARDEKANI M.D.

Nephrology

749

$50.7K

85
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $114

PADMAJA KOLACHANA M.D.

Nephrology

722

$87.4K

63
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$121
Average prescription price

Avg: $114

PAUL LAFLAM M.D.

Nephrology

712

$40.9K

106
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $114

VINEETA SOOD MD

Nephrology

680

$53.6K

87
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$79
Average prescription price

Avg: $114

KRUNAL PATEL MD

Nephrology

670

$90.9K

70
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 28%

$136
Average prescription price

Avg: $114

ANDREW PENG M.D.

Nephrology

669

$77.8K

138
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$116
Average prescription price

Avg: $114

REBECCA GOBLE N.P.

Nephrology

648

$77.7K

50
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $114

EMAAD ABDEL-RAHMAN

Nephrology

621

$84K

108
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$135
Average prescription price

Avg: $114

ROBERT CANADY M.D.

Nephrology

590

$39K

140
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $114

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank